[Follow-up of patients after an acute coronary event: the Apulia PONTE-SCA program].

医学 内科学 急性冠脉综合征 心脏病学 不稳定型心绞痛 血运重建 再狭窄 狼牙棒 支架 阿司匹林 心肌梗塞 经皮冠状动脉介入治疗
作者
Nicola Locuratolo,Pietro Scicchitano,Ettore Antoncecchi,P Basso,V. M. Bonfantino,F. Brescia,Francesco Carrata,Giulia Martino,Raffaella Landriscina,Saverio Lanzone,A. Di Lillo,Francesco Massari,Sergio Musci,Vincenzo Davide Palumbo,Claudio Paolillo,David Rutigliano,Sergio Rutigliano,Lucia Sublimi Saponetti,Giuseppe Scalera,Teresa Spadafina,Elisabetta Squiccimarro,Francesco Tota,Pasquale Caldarola
出处
期刊:PubMed 卷期号:23 (1): 63-74 被引量:3
标识
DOI:10.1714/3715.37064
摘要

Patients who suffered from acute coronary syndrome (ACS) need a tight follow-up in order to optimize therapy and prevent adverse events. The aim of the PONTE-SCA Puglia program was to evaluate the impact of an integrated management of patients between hospital and local territorial outpatient facilities on adherence and outcome of patients discharged after ACS event.This was a prospective, longitudinal, cohort study which enrolled patients who suffered ACS and/or coronary revascularization in a Hub hospital of ASL Bari. Patients underwent clinical and laboratory evaluation at 30 days, 3 months, 6 months, and 1 year after the index event. The following endpoints were considered: all-cause mortality, ACS recurrence/cardiac ischemia/angina, restenosis/intrastent thrombosis, stroke/transient ischemic attack, heart failure, all-cause bleeding. We evaluated persistence on therapies and the percentage of patients who attained therapeutic goals.A total of 2476 patients (mean age 67.2 ± 12.0 years, 77.4% male) were enrolled. At 1-year follow-up, 99.5% of patients (p<0.05) were on statin therapy, 16.1% (p<0.01) on ezetimibe, and 9.9% (p<0.01) on proprotein convertase subtilisin/kexin type 9 inhibitors. All-cause mortality was 3.1% at 1-year follow-up, whereas recurrence of ACS/cardiac ischemia/angina and restenosis/stent thrombosis were 3% and 1.3%, respectively. The prevalence of all bleeding complications was 2.2%.The PONTE-SCA Puglia program allowed to implement a dedicated taking in charge of patients after an ACS/coronary revascularization event, to manage a dedicated follow-up route for them, to ameliorate persistence on recommended therapies, and to keep lower the incidence of major adverse cardiovascular events and bleedings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
魏1122发布了新的文献求助30
2秒前
英姑应助TAA66采纳,获得10
2秒前
3秒前
iuv发布了新的文献求助10
5秒前
9秒前
10秒前
12秒前
12秒前
13秒前
今后应助魏1122采纳,获得10
14秒前
14秒前
15秒前
111发布了新的文献求助10
16秒前
17秒前
AAAAA发布了新的文献求助10
18秒前
chili发布了新的文献求助10
19秒前
oceanao应助王安娜采纳,获得10
20秒前
万刈应助roger969采纳,获得30
21秒前
一样不一样完成签到,获得积分10
21秒前
酷波er应助AAAAA采纳,获得10
23秒前
kerio发布了新的文献求助10
23秒前
子车茗应助Huang采纳,获得10
24秒前
深情安青应助任我行采纳,获得10
25秒前
出其东门完成签到,获得积分10
26秒前
寒冷荧荧应助冷静新烟采纳,获得10
26秒前
27秒前
28秒前
bunniesfly完成签到,获得积分10
30秒前
zz发布了新的文献求助10
32秒前
无敌小汐完成签到,获得积分10
32秒前
李白发布了新的文献求助10
32秒前
34秒前
邢智超完成签到 ,获得积分20
34秒前
36秒前
沐沐完成签到 ,获得积分10
38秒前
38秒前
科研通AI2S应助李白采纳,获得10
39秒前
皆空发布了新的文献求助10
39秒前
任我行发布了新的文献求助10
40秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3161167
求助须知:如何正确求助?哪些是违规求助? 2812556
关于积分的说明 7895642
捐赠科研通 2471395
什么是DOI,文献DOI怎么找? 1315977
科研通“疑难数据库(出版商)”最低求助积分说明 631074
版权声明 602112